Publication | Closed Access
The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells
120
Citations
0
References
2000
Year
ImmunologyPathologyImmunotherapyCancer BiologyTumor BiologyHematological MalignancyMyeloma CellsMolecular DiagnosticsRadiation OncologyCancer ResearchHuman Myeloma CellsMedicineCancer GeneticsCell BiologyTumor MicroenvironmentCancer ImmunosurveillanceMalignant Blood DisorderMyeloma Cell LinesCancer GenomicsMultiple MyelomaOncology
In this study, we have investigated the mRNA expression of the cancer germ-line genes MAGE, BAGE, GAGE, RAGE and the tumor-overexpressed gene PRAME by human myeloma cell lines and malignant plasma cells from patients with multiple myeloma (MM). By reverse transcription-PCR, we show that all myeloma cell lines (n = 16) express at least one of these genes, except RAGE-1 that was never expressed. We show that malignant plasma cells from the majority of MM patients (n = 21) expressed MAGE-1, MAGE-3 and PRAME. On the contrary, polyclonal reactive plasma cells did not express any of these genes. By flow cytometry, we show that mage-1 protein is expressed within myeloma cells and cell lines and that anti-mage-1.HLA-A1 cytotoxic T lymphocytes efficiently killed MAGE-1+HLA-A1+ MDN myeloma cells. Taken together, our data show that mage-1 and mage-3 could constitute specific targets for tumor immunotherapy of MM patients.